FeesSafety
Pluang+

Nomad Foods seen as a strong buy at $11.65 with 40% upside potential despite volume declines.

Analyst Insights
16 Nov 2026, 16:31 WIB
Seeking Alpha
View Source
Bullish
Nomad Foods seen as a strong buy at $11.65 with 40% upside potential despite volume declines.

Nomad Foods is currently trading at $11.65, considered a strong buy with a potential 40% upside to a fair value of $16.30 based on 2026 earnings guidance. The company’s Q3 organic sales grew by 1.6%, although volume slightly declined by 0.2%, and profits remain pressured by inflation and higher financing costs. While the dividend yield is attractive at 5.84% and well covered by full-year estimates, ongoing volume declines, operating leverage, and debt pose risks to cash flow and dividend sustainability. Investors see value in the stock due to its significant price drop from over $30 in 2021, suggesting long-term upside despite near-term challenges.

Nomad Foods is highlighted with a nearly 6% dividend yield and notable upside potential. For readers following the Consumer Staples sector, here is Pluang's market snapshot as of Nov 16, 2026 19:13 WIB: out of 63 priced US stocks, 44 rose and 11 fell. Notable movers include Campbell Soup Co. at USD 23.10 with a 1-day change of +1.47%, Kimberly Clark Corp at USD 110.99 with +1.43%, and e l f Beauty Inc at USD 116.50 with -1.25%.

More News

Walk assist robot market to grow 15% CAGR by 2031, driven by AI, aging population, and stroke rehab demand

Walk assist robot market to grow 15% CAGR by 2031, driven by AI, aging population, and stroke rehab demand

The global walk assist robot market is projected to grow at a 15.01% CAGR from 2024 to 2031, fueled by advances in AI, machine learning, and hybrid wearable technology. Rising stroke incidence and an aging population are increasing demand for these r...

Market News
Bullish
1 hour ago
Anti-obesity drug market to hit $64.96B by 2035, led by Eli Lilly and Novo Nordisk with strong new drug launches.

Anti-obesity drug market to hit $64.96B by 2035, led by Eli Lilly and Novo Nordisk with strong new drug launches.

The global anti-obesity drugs market is projected to grow from USD 8.96 billion in 2026 to USD 64.96 billion by 2035, driven by a CAGR of 24.71%. Eli Lilly and Novo Nordisk dominate the market with blockbuster drugs like Mounjaro, Zepbound, and Wegov...

Bullish
1 hour ago
Sandisk announces 8-for-1 stock split effective Nov 19, focusing on flash memory prices over share count.

Sandisk announces 8-for-1 stock split effective Nov 19, focusing on flash memory prices over share count.

Sandisk will execute an 8-for-1 stock split on November 19, 2026, increasing the number of shares outstanding while reducing the price per share. Despite this split, the company emphasizes that flash memory prices remain the key factor influencing it...

Company Fundamentals
Neutral
1 hour ago
Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
1 hour ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App